North America Cartilage Degeneration Market to Grow at a CAGR of 4.7% to reach US$ 6,998.45 Million from 2020 to 2027

North America Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country

  • Report Code : TIPRE00014166
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 113
Buy Now

The North America cartilage degeneration market is expected to reach US$ 6,998.45 million by 2027 from US$ 4,889.27 million in 2019; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027.

The increasing prevalence of sports injuries and obesity is driving the growth of cartilage degeneration in this region. However, the high cost of cartilage therapies is hindering the market growth in North America.

Degeneration of cartilage can lead to pain and chronic inflammation in joints of a human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

According to a study published by the Centers for Disease Control and Prevention (CDC), the prevalence of obesity grew from 30.5% to 42.4% during the past two decades in the US. Obesity has a considerable effect on the musculoskeletal system, resulting in the degeneration of bones, cartilage, and ligaments. Moreover, the condition along with other prominent factors, is strongly allied with the increased risk of rapid cartilage loss. Also, overweight conditions among players and athletes can lead to an increasing prevalence of sports injuries. Such association between obesity and cartilage degeneration is anticipated to drive the market growth by 2027.

As the COVID-19 pandemic continues to unfold in the North American countries, medical device companies are finding difficulties in managing their operations. Many companies operating in the US and offering products for cartilage regeneration have been affected by the effects of the COVID-19 crisis. The pandemic has disrupted and restricted the abilities of the companies to distribute products as well as led to temporary closures of the facilities. Also, hospitals have postponed or canceled elective surgeries to free-up limited space and transform operating rooms into intensive care units. These factors associated with the current pandemic are affecting the growth of the North America cartilage degeneration market

Mexico Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Million)

Mexico Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Million)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

North America Cartilage Degeneration Market segmentation

By Procedure Type

  • Joint Replacement
  • Chondroplasty
  • Cell-based Cartilage Resurfacing
  • Osteochondral Transplant
  • Meniscus Transplants
  • Others

By Application

  • Knee
  • Hips
  • Others

By End User

  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Academic & Research Institutes

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Zimmer Biomet
  • Stryker Corporation
  • Johnson and Johnson Services, Inc.
  • CONMED Corporation
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Procedure Type, Application, and End User and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Cartilage Degeneration Market – By Procedure Type

1.3.2 North America Cartilage Degeneration Market – By Application

1.3.3 North America Cartilage Degeneration Market– By End User

1.3.4 North America Cartilage Degeneration Market – By Country

2. North America Cartilage Degeneration Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Cartilage Degeneration Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Cartilage Degeneration Market - North America PEST Analysis

4.3 Expert Opinion

5. North America Cartilage Degeneration Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Growing Number of Sports Injuries

5.1.2 Increasing Prevalence of Obesity

5.2 Key Market Restraints

5.2.1 High Cost of Cartilage Repair Therapies

5.3 Key Market Opportunities

5.3.1 Growing Number of Product Approvals and Developments

5.4 Future Trends

5.4.1 Rising Emphasis on Regenerative Medicines

5.5 Impact analysis

6. Cartilage Degeneration Market – North America Analysis

6.1 North America Cartilage Degeneration Market Revenue Forecasts and Analysis

7. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Procedure Type

7.1 Overview

7.2 North America Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)

7.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)

7.3 Osteochondral Transplant

7.3.1 Overview

7.3.2 North America Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Chondroplasty

7.4.1 Overview

7.4.2 North America Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Joint Replacement

7.5.1 Overview

7.5.2 North America Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)

7.6 Meniscus Transplants

7.6.1 Overview

7.6.2 North America Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)

7.7 Cell-based Cartilage Resurfacing

7.7.1 Overview

7.7.2 North America Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)

7.8 Other Procedures

7.8.1 Overview

7.8.2 North America Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Application

8.1 Overview

8.2 North America Cartilage Degeneration Market, By Application 2019 & 2027 (%)

8.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3 Knee

8.3.1 Overview

8.3.2 North America Knee Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Hip

8.4.1 Overview

8.4.2 North America Hip Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Other Applications

8.5.1 Overview

8.5.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Cartilage Degeneration Market Analysis – By End-User

9.1 Overview

9.2 North America Cartilage Degeneration Market, By End-User 2019-2027 (%)

9.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

9.3 Hospitals and Specialty Centres

9.3.1 Overview

9.3.2 North America Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Ambulatory Surgical Centres

9.4.1 Overview

9.4.2 North America Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 North America Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10. Cartilage degeneration Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1 North America Cartilage degeneration Market Revenue and Forecasts To 2027

10.1.1 Overview

10.1.2 North America: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.3 North America: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)

10.1.4 North America: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)

10.1.5 North America: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)

10.1.6 North America: Cartilage Degeneration Market, by Country, 2019& 2027 (%)

10.1.7 US: Cartilage Degeneration Market– Revenue and Forecast to 2027 (USD Million)

10.1.7.1 US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 US: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)

10.1.7.3 US: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)

10.1.7.4 US: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)

10.1.8 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Canada: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)

10.1.8.3 Canada: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)

10.1.8.4 Canada: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)

10.1.9 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3 Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4 Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Cartilage degeneration Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 Zimmer Biomet

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Stryker Corporation

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Johnson and Johnson Services, Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 CONMED Corporation

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Anika Therapeutics, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Arthrex, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By Procedure Type (US$ Mn)

Table 2. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 4. North America Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 5. North America Cartilage Degeneration Market, by Application, – Revenue and Forecast to 2027 (USD Million)

Table 6. North America Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. US Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 8. US Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 9. US Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16. Glossary of Terms, Cartilage Degeneration Market

LIST OF FIGURES

Figure 1. Cartilage Degeneration Market Segmentation

Figure 2. North America Cartilage Degeneration Market Overview

Figure 3. Knee Segment Held Largest Share of Cartilage Degeneration Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. North America Cartilage Degeneration Market - Leading Country Markets (US$ Mn)

Figure 6. Cartilage Degeneration Market - North America PEST Analysis

Figure 7. Cartilage Degeneration Market Impact Analysis of Driver and Restraints

Figure 8. North America Cartilage degeneration Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. North America Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)

Figure 10. North America Osteochondral Transplant Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. North America Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. North America Joint Replacement Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. North America Meniscus Transplants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. North America Cell-based Cartilage Resurfacing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15. North America Other Procedures Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. North America Cartilage Degeneration Market, By Application 2019 & 2027 (%)

Figure 17. North America Knee Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. North America Hip Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. North America Cartilage Degeneration Market, by End-User 2019 & 2027 (%)

Figure 21. North America Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. North America Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. North America: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)

Figure 25. North America Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)

Figure 26. North America: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)

Figure 27. US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 28. Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 29. Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Impact of COVID-19 Pandemic in North American Country Markets

The List of Companies - North America Cartilage Degeneration Market

  1. Zimmer Biomet
  2. Stryker Corporation
  3. Johnson and Johnson Services, Inc.
  4. CONMED Corporation
  5. Arthrex, Inc.
  6. Anika Therapeutics, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Cartilage Degeneration Market